Gelonghui, December 10, 丨 Huabang Health (002004.SZ) announced that the company held the 21st meeting of the 8th board of directors on December 10, 2024 to review and pass the “Proposal on the Company's Non-Public Issuance of Exchangeable Corporate Bonds”, “Proposal on Requesting the Shareholders' Meeting to Authorize the Board of Directors to Handle Matters Relating to the Non-public Issuance of Exchangeable Corporate Bonds” and other related proposals. Taking fully into account the company's development strategy and taking into account the company's actual situation, the company plans to issue non-public exchangeable corporate bonds (hereinafter referred to as “this bond”) to professional institutional investors. This bond must still be submitted to the shareholders' meeting for consideration.
The total size of this bond does not exceed 1 billion yuan (including 1 billion yuan), and can be issued at one time or in installments. The specific distribution scale and period shall be determined by the shareholders' meeting authorized by the board of directors (or authorized person of the board of directors) to negotiate with the lead underwriter within the above scope based on the company's capital requirements and market conditions at the time of issuance.